Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Starlix Takes Aim At Diabetes Prevention With 8,000-Patient Study

Feb 26 2001

• By The Pink Sheet

Related Content

Genentech Xolair Brand Awareness Reaches 55% Among Allergists

Feb 26 2001

Novartis Zelmac Trade Name Could Be Changed Following FDA Discussions

Feb 19 2001

Novartis To Launch Anti-Diabetic Starlix In February With Firm's 4,000 Reps

Jan 08 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window